Manufacturer
83 recalls in our database name Teva Pharmaceuticals USA, Inc. as the manufacturing or recalling firm.
Of the 83 recalls from Teva Pharmaceuticals USA, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (10%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Teva Pharmaceuticals is recalling specific lots of Valganciclovir Hydrochloride for Oral Solution because brown or black particles were found during stability testing.
Teva Pharmaceuticals USA is recalling Valacyclovir Hydrochloride 1 g tablets because bottles may contain fragments of Pravastatin tablets.
Teva Pharmaceuticals is recalling Fluconazole Oral Suspension because the product has preservative levels below the required specification.
Teva Pharmaceuticals is recalling CARBOplatin Injection because the required reduction of endotoxin was not met during annual revalidation of the vial washer.
Teva Pharmaceuticals is recalling specific lots of Propranolol Hydrochloride 10 mg tablets because some may not meet weight specifications.
Teva Pharmaceuticals is recalling 7,579 bottles of Methylphenidate Hydrochloride Extended-Release Capsules because routine stability testing revealed out-of-specification dissolution results.
Teva Pharmaceuticals is recalling 13,478 bottles of Methylphenidate Hydrochloride Extended-Release Capsules because routine stability testing revealed out-of-specification dissolution results.
Teva Pharmaceuticals is recalling 6,267 bottles of Terazosin Hydrochloride capsules because the 10 mg label contained 5 mg capsules.
Teva Pharmaceuticals is recalling 16,293 bottles of Methylphenidate Hydrochloride Extended-Release Capsules because routine stability testing revealed out-of-specification dissolution results.
Teva Pharmaceuticals is recalling specific lots of Amoxicillin for Oral Suspension because of orange to brown discoloration found on the inner foil seal.
Teva Pharmaceuticals is recalling Camila (norethindrone) tablets because an impurity called N-Butyl-Benzene Sulfonamide was detected during testing.
Teva Pharmaceuticals is recalling Balziva (norethindrone and ethinyl estradiol) tablets because an impurity was detected during testing.
Teva Pharmaceuticals is recalling Errin (norethindrone) tablets because an impurity called N-Butyl-Benzene Sulfonamide was detected during testing.
Teva Pharmaceuticals is recalling specific lots of Jolessa birth control tablets because an impurity was detected during testing.
Teva Pharmaceuticals is recalling Junel oral contraceptives because an impurity called N-Butyl-Benzene Sulfonamide was detected during testing.
Teva Pharmaceuticals is recalling Lessina oral contraceptives because an impurity was detected during testing. The FDA classifies this as a Class III recall.
Teva Pharmaceuticals is recalling 316 cartons of Actiq 200 mcg fentanyl lozenges because they failed dissolution specifications during stability testing.
Teva Pharmaceuticals is recalling Amoxicillin for Oral Suspension due to yellow to brown discoloration on the inner foil seal.
Teva Pharmaceuticals is recalling 68,322 bottles of Disulfiram Tablets USP 250 mg because some packaged bottles are missing a cotton coil.
Teva Pharmaceuticals is recalling Camrese oral contraceptives because an impurity called N-Butyl-Benzene Sulfonamide was detected during testing.
Teva Pharmaceuticals is recalling Seasonale tablets because testing detected an impurity called N-Butyl-Benzene Sulfonamide.
Teva Pharmaceuticals is recalling 6,692 boxes of Copaxone (glatiramer acetate) injection due to visible medical grade silicone oil in the syringes.
Teva Pharmaceuticals is recalling 62,187 bottles of Cefdinir for Oral Suspension because some bottles may be improperly sealed.
Teva Pharmaceuticals is recalling specific lots of Jolessa tablets because they failed appearance specifications. The recall is nationwide.
Teva Pharmaceuticals is recalling Portia (levonorgestrel and ethinyl estradiol) tablets because they failed appearance specifications.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Teva Pharmaceuticals CR
company in Prague, Czechia
Source: Wikidata (Q41567143), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.